SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
33 hedge funds and large institutions have $92.4M invested in scPharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
0.16% less ownership
Funds ownership: 59.7% → 59.54% (-0.16%)
Holders
33
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$7.95M | |
| 2 | +$2.01M | |
| 3 | +$854K | |
| 4 |
Millennium Management
New York
|
+$259K |
| 5 |
Renaissance Technologies
New York
|
+$213K |
Top Sellers
| 1 | -$1.25M | |
| 2 | -$243K | |
| 3 | -$101K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$90K |
| 5 |
AIM
Alambic Investment Management
Belvedere,
California
|
-$70.2K |